Medical Devices Acquisitions in Maryland

Maryland Medical Devices M&A Themes

Maryland-based medical device and healthcare tech acquisitions span multiple subsectors—from ophthalmic diagnostics and interventional radiology to rapid diagnostics and regenerative-medicine platforms. Across recent transactions listed here, buyers commonly expand product breadth, add manufacturing or distribution capabilities, or bring new technology into established portfolios.

Deal activity also reflects a mix of strategic buyers and healthcare-focused investors. Examples include AMETEK, Inc. acquiring LKC Technologies to expand ophthalmic offerings, and Halma plc purchasing IZI Medical Products to strengthen a healthcare group’s interventional radiology consumables and hospital customer base.

Private equity-backed platforms appear as well, including DW Healthcare Partners’ investment in LKC Technologies and Avidity Science’s consolidation of multiple life-science research equipment and water purification-related businesses supported by ShoreView Partners. Together, these transactions show how Maryland acquirers pair technology and operational assets to support growth in diagnostics, lab and research enablement, and medical device applications.

What Stands Out

  • AMETEK, Inc. added a Germantown, Maryland ophthalmic diagnostic device maker, extending its ophthalmic product portfolio.
  • Halma plc acquired IZI Medical Products to broaden consumable offerings and hospital distribution within interventional radiology.
  • Rapid diagnostics and bioprocessing themes appear: Heska Corporation moved into veterinary point-of-care lateral flow assays via Biotech Laboratories U.S.A. LLC.
  • Regenerative medicine and platform expansion are represented by Integra LifeSciences’ acquisition of ACell, Inc. and its MatriStem platform.
Buyer What the acquisition reinforced
AMETEK, Inc. Ophthalmic diagnostic devices
Halma plc Interventional radiology consumables + hospital base
Integra LifeSciences Regenerative-medicine tissue technologies
  • Buyer
    AMETEK, Inc.
    Target
    LKC Technologies
    Seller
    DW Healthcare Partners
    Industry
    Medical Devices
    Type
    Buyout

    AMETEK, Inc. has acquired LKC Technologies, a Germantown, Maryland-based maker of portable ophthalmic diagnostic devices, including the RETeval handheld ERG system. The seller was DW Healthcare Partners, which had owned LKC as a portfolio company; AMETEK said the deal expands its ophthalmic product portfolio and complements its Ultra Precision Technologies Reichert business.

  • Buyer
    UFP Technologies, Inc.
    Target
    Universal Plastics & Engineering Company, Inc. (UNIPEC), Techno Plastics Industries, Inc. (TPI)
    Seller
    UNIPEC shareholders (Brandt Berghers and family)
    Industry
    Medical Devices
    Type
    Buyout

    UFP Technologies, Inc. (Nasdaq: UFPT) acquired Universal Plastics & Engineering Company, Inc. (UNIPEC) of Rockville, Maryland, and Techno Plastics Industries, Inc. (TPI) of Añasco, Puerto Rico to expand its film and thermoplastic molding capabilities for the medical device market. UNIPEC (≈$5M revenue, $2M EBITDA) and TPI (≈$10M revenue, $1M EBITDA) will bolster UFP's thin-film and injection-molding capacity for implantable and other high-barrier medical applications; the deals were financed with cash and borrowings under UFP's credit facility.

  • Buyer
    SERB Pharmaceuticals
    Target
    RSDL (Reactive Skin Decontamination Lotion) kit
    Seller
    Emergent BioSolutions Inc.
    Industry
    Medical Devices

    SERB Pharmaceuticals purchased the RSDL (Reactive Skin Decontamination Lotion) kit and related inventory, contracts and operations from Emergent BioSolutions for approximately $75 million, with an additional $5 million contingent milestone payment. The deal includes the Hattiesburg, Mississippi leased manufacturing facility and several site-based employees (who will join SERB), while Emergent's Winnipeg facility will continue to supply bulk lotion under a long-term supply agreement; Emergent said the divestiture supports debt reduction and portfolio rationalization.

  • Buyer
    DW Healthcare Partners
    Target
    LKC Technologies, Inc.
    Industry
    Medical Devices

    DW Healthcare Partners, a healthcare-focused private equity firm, completed an investment in LKC Technologies, maker of the handheld RETeval electroretinography/visual evoked potential device. The transaction positions LKC to scale its diagnostic medical-device business globally under new CEO Dina Dubey as founder Jim Datovech transitions from the CEO role.

  • Buyer
    Frontier Dental Lab Group, O2 Investment Partners
    Target
    Friendship Dental Laboratories, LLC
    Industry
    Medical Devices
    Type
    Addon

    Frontier Dental Lab Group has partnered with and made an investment in Friendship Dental Laboratories, a full-service dental laboratory based in Rosedale, Maryland. The transaction, supported by O2 Investment Partners, brings Friendship onto Frontier's multi-site dental lab platform (George Diacoloukas will join Frontier's board) to expand the platform's Mid-Atlantic presence and capabilities.

  • Buyer
    Halma plc
    Target
    IZI Medical Products
    Seller
    Shore Capital Partners
    Industry
    Medical Devices

    Halma plc has acquired IZI Medical Products, an interventional radiology medical device manufacturer and distributor, from Shore Capital Partners. The deal — which closed on September 30, 2022 — brings IZI's consumable device portfolio and hospital customer base into Halma's healthcare group to expand capabilities, R&D and international growth opportunities.

  • Buyer
    Blackrock Neurotech
    Target
    MindX
    Industry
    Medical Devices
    Type
    Buyout

    Blackrock Neurotech has acquired spatial computing software firm MindX, integrating MindX’s MindOS spatial neurocomputing, AR and AI capabilities with Blackrock’s implantable BCI hardware. The acquisition brings MindX’s founder Julia Brown and her team into Blackrock to accelerate commercialization of a full‑stack BCI platform and bolster patient‑facing software and AI capabilities.

  • Buyer
    Heska Corporation
    Target
    Biotech Laboratories U.S.A. LLC
    Seller
    Biotech Holdings U.S.A. LLC
    Industry
    Medical Devices
    Type
    Buyout

    Heska Corporation acquired majority ownership of Biotech Laboratories U.S.A. LLC, a Rockville, Maryland developer of rapid point-of-care lateral flow diagnostics for animals. The acquisition (closed Sept. 1, 2021) brings Biotech's rapid assay pipeline, manufacturing expertise and IP into Heska's product portfolio as the company moves to launch a full line of single-use rapid assays for veterinarians and livestock producers.

  • Buyer
    Integra LifeSciences
    Target
    ACell, Inc.
    Industry
    Medical Devices
    Type
    Buyout

    Integra LifeSciences agreed to acquire regenerative-medicine company ACell, Inc. for $300 million upfront in cash plus up to $100 million in revenue-based milestones. The acquisition adds ACell's MatriStem porcine urinary bladder matrix platform to Integra's tissue technologies portfolio and is expected to close in Q1 2021, subject to customary conditions.

  • Buyer
    Avidity Science, ShoreView Partners
    Target
    Lab Products, Inc., Bio Medic Data Systems, Hydropac, Harford Systems
    Industry
    Medical Devices
    Type
    Addon

    Avidity Science, a ShoreView portfolio company, has acquired Lab Products, Inc. and its divisions — Bio Medic Data Systems, Hydropac and Harford Systems — expanding its portfolio of water purification and delivery products, control and monitoring solutions, and vivarium equipment for biomedical research. The transaction is the fifth add-on completed under ShoreView's ownership and is intended to broaden Avidity's product capabilities and geographic presence in the life-science research market.

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.

Frequently Asked Questions

Which subsectors within medical devices show up in Maryland deals here?

The listed acquisitions touch ophthalmic diagnostics, interventional radiology consumables, rapid veterinary diagnostics, spatial/brain-computer interface technology, regenerative medicine, and certain medical/lab enabling platforms (e.g., research equipment and water purification).

Are these Maryland acquisitions mostly strategic buyers or investors?

Both appear. Strategic operators include AMETEK, Inc., Halma plc, Integra LifeSciences, Heska Corporation, and others, alongside healthcare-focused private equity activity such as DW Healthcare Partners and ShoreView Partners.

Do the deals typically emphasize product portfolio expansion?

Yes. Multiple transaction summaries describe expanding ophthalmic, interventional radiology, diagnostics, or tissue/regenerative-medicine portfolios, often by adding platforms, consumables, or technology and related operational assets.

Where in Maryland are these acquisitions located?

The page facts reference Maryland, United States, including locations such as Germantown and Rockville tied to specific target companies.

Related Acquisition Pages